Pharmaniaga seen as among frontrunners for vaccine tender


MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.

PETALING JAYA: Positive developments in the development of a Covid-19 vaccine will continue to lift interest in local pharmaceutical manufacturers, including Pharmaniaga Bhd, which is touted to be among the frontrunners to win a tender for the vaccine.

MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Oharmaniaga , vaccine , frontrunners , Doupharma ,

Next In Business News

TNB’s LNG move boosts long-term growth outlook
Tanjung Embang set to become Sarawak green growth hub
Pekat’s prospects brighten on solar job
Global IPOs unlikely to trigger outflows
Malaysia’s growth paradox
Altice France sells SFR in US$23bil deal
Jakarta’s commodities reality check
Bulls seek protection in world’s hottest market
MISC’s�carbon capture and storage push deepens with new charter deal
High fuel costs set to trigger airline consolidation

Others Also Read